Is Sarepta the Next Biotech Success Story?

Motley Fool Health-Care Analyst David Williamson discusses the earnings report and conference call released yesterday from Sarepta, and talks about why it may be the next biotech company to keep your eye on. Like any biotech company in the development stage, Sarepta didn't have a whole lot of earnings to report, but the conference call was full of great information. Williamson breaks down all the things he liked, and some of the things he didn't, from this exciting company's quarter.

When it comes to do-or-die businesses, the biotech industry takes the cake. Another recent success story that we've been watching very closely is Arena Pharmaceuticals, especially after it gained FDA approval for its innovative obesity drug. While the future looks bright for Arena, there are still plenty of obstacles ahead. In our brand new premium research report on Arena Pharmaceuticals, we walk investors through the must-know opportunities and threats facing the company. Since key news can develop quickly, we're also including a full year of updates for those who sign up. Click here now to learn more.

Read/Post Comments (0) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2103743, ~/Articles/ArticleHandler.aspx, 10/28/2016 12:20:14 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,230.08 60.40 0.33%
S&P 500 2,138.74 5.70 0.27%
NASD 5,216.98 1.01 0.02%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 12:04 PM
ALXN $132.16 Up +0.79 +0.60%
Alexion Pharmaceut… CAPS Rating: ***
ARNA $1.53 Down -0.04 -2.24%
Arena Pharmaceutic… CAPS Rating: ***
DNDNQ $0.00 Down +0.00 +0.00%
Dendreon Corp CAPS Rating: *
SRPT $41.09 Up +0.28 +0.69%
Sarepta Therapeuti… CAPS Rating: **
SNY $39.02 Up +1.77 +4.76%
Sanofi CAPS Rating: *****